Literature DB >> 30297365

Breaking the Vicious Cycle of Antibiotic Killing and Regrowth of Biofilm-Residing Pseudomonas aeruginosa.

Mathias Müsken1,2, Vinay Pawar3,2,4,5, Timo Schwebs3,2, Heike Bähre6, Sebastian Felgner3,2, Siegfried Weiss4,5, Susanne Häussler3,2.   

Abstract

Biofilm-residing bacteria embedded in an extracellular matrix are protected from diverse physicochemical insults. In addition to the general recalcitrance of biofilm bacteria, high bacterial loads in biofilm-associated infections significantly diminish the efficacy of antimicrobials due to a low per-cell antibiotic concentration. Accordingly, present antimicrobial treatment protocols that have been established to serve the eradication of acute infections fail to clear biofilm-associated chronic infections. In the present study, we applied automated confocal microscopy on Pseudomonas aeruginosa to monitor dynamic killing of biofilm-grown bacteria by tobramycin and colistin in real time. We revealed that the time required for surviving bacteria to repopulate the biofilm could be taken as a measure for effectiveness of the antimicrobial treatment. It depends on the (i) nature and concentration of the antibiotic, (ii) duration of antibiotic treatment, (iii) application as monotherapy or combination therapy, and (iv) interval of drug administration. The vicious cycle of killing and repopulation of biofilm bacteria could also be broken in an in vivo model system by applying successive antibiotic dosages at intervals that do not allow full reconstitution of the biofilm communities. Treatment regimens that consider the important aspects of antimicrobial killing kinetics bear the potential to improve control of biofilm regrowth. This is an important and underestimated factor that is bound to ensure sustainable treatment success of chronic infections.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  Pseudomonas aeruginosazzm321990; biofilm regrowth; biofilm treatment; killing kinetics; treatment optimization

Mesh:

Substances:

Year:  2018        PMID: 30297365      PMCID: PMC6256772          DOI: 10.1128/AAC.01635-18

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  61 in total

1.  Multidrug efflux pumps: expression patterns and contribution to antibiotic resistance in Pseudomonas aeruginosa biofilms.

Authors:  T R De Kievit; M D Parkins; R J Gillis; R Srikumar; H Ceri; K Poole; B H Iglewski; D G Storey
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

2.  New device for high-throughput viability screening of flow biofilms.

Authors:  Michael R Benoit; Carolyn G Conant; Cristian Ionescu-Zanetti; Michael Schwartz; A Matin
Journal:  Appl Environ Microbiol       Date:  2010-04-30       Impact factor: 4.792

3.  Antimicrobial Tolerance in Biofilms.

Authors:  Philip S Stewart
Journal:  Microbiol Spectr       Date:  2015-06

Review 4.  Cystic fibrosis: an inherited susceptibility to bacterial respiratory infections.

Authors:  B Tümmler; C Kiewitz
Journal:  Mol Med Today       Date:  1999-08

5.  Elucidation of the pharmacokinetic/pharmacodynamic determinant of colistin activity against Pseudomonas aeruginosa in murine thigh and lung infection models.

Authors:  Rajesh V Dudhani; John D Turnidge; Kingsley Coulthard; Robert W Milne; Craig R Rayner; Jian Li; Roger L Nation
Journal:  Antimicrob Agents Chemother       Date:  2009-12-22       Impact factor: 5.191

6.  In Vivo Efficacy of Antimicrobials against Biofilm-Producing Pseudomonas aeruginosa.

Authors:  Vinay Pawar; Uliana Komor; Nadine Kasnitz; Piotr Bielecki; Marina C Pils; Benjamin Gocht; Annette Moter; Manfred Rohde; Siegfried Weiss; Susanne Häussler
Journal:  Antimicrob Agents Chemother       Date:  2015-06-08       Impact factor: 5.191

Review 7.  Inhaled antibiotics beyond aminoglycosides, polymyxins and aztreonam: A systematic review.

Authors:  Matthew E Falagas; Kyriakos K Trigkidis; Konstantinos Z Vardakas
Journal:  Int J Antimicrob Agents       Date:  2014-11-06       Impact factor: 5.283

8.  Biofilm formation by Salmonella enterica serovar Typhimurium colonizing solid tumours.

Authors:  Katja Crull; Manfred Rohde; Kathrin Westphal; Holger Loessner; Kathrin Wolf; Alfonso Felipe-López; Michael Hensel; Siegfried Weiss
Journal:  Cell Microbiol       Date:  2011-05-25       Impact factor: 3.715

Review 9.  Systematic review of the dry powder inhalers colistimethate sodium and tobramycin in cystic fibrosis.

Authors:  Lesley Uttley; Sue Harnan; Anna Cantrell; Chris Taylor; Martin Walshaw; Keith Brownlee; Paul Tappenden
Journal:  Eur Respir Rev       Date:  2013-12

10.  Cationic antimicrobial peptides activate a two-component regulatory system, PmrA-PmrB, that regulates resistance to polymyxin B and cationic antimicrobial peptides in Pseudomonas aeruginosa.

Authors:  Joseph B McPhee; Shawn Lewenza; Robert E W Hancock
Journal:  Mol Microbiol       Date:  2003-10       Impact factor: 3.501

View more
  10 in total

1.  CORR Insights®: Halicin Is Effective Against Staphylococcus aureus Biofilms In Vitro.

Authors:  Beata Leeb-Zatorska
Journal:  Clin Orthop Relat Res       Date:  2022-06-20       Impact factor: 4.755

Review 2.  Ways to control harmful biofilms: prevention, inhibition, and eradication.

Authors:  Wen Yin; Siyang Xu; Yiting Wang; Yuling Zhang; Shan-Ho Chou; Michael Y Galperin; Jin He
Journal:  Crit Rev Microbiol       Date:  2020-12-28       Impact factor: 7.624

3.  IL-1β Promotes Staphylococcus aureus Biofilms on Implants in vivo.

Authors:  Rodrigo Gutierrez Jauregui; Henrike Fleige; Anja Bubke; Manfred Rohde; Siegfried Weiss; Reinhold Förster
Journal:  Front Immunol       Date:  2019-05-17       Impact factor: 7.561

Review 4.  Salmonella Biofilm Formation, Chronic Infection, and Immunity Within the Intestine and Hepatobiliary Tract.

Authors:  Jaikin E Harrell; Mark M Hahn; Shaina J D'Souza; Erin M Vasicek; Jenna L Sandala; John S Gunn; James B McLachlan
Journal:  Front Cell Infect Microbiol       Date:  2021-02-02       Impact factor: 5.293

5.  Behavior of the Surviving Population of Listeria monocytogenes and Salmonella Typhimurium Biofilms Following a Direct Helium-Based Cold Atmospheric Plasma Treatment.

Authors:  Marlies Govaert; Cindy Smet; Cyril Acquah; James L Walsh; Jan F M Van Impe
Journal:  Front Microbiol       Date:  2022-03-24       Impact factor: 5.640

Review 6.  Combination Therapies for Biofilm Inhibition and Eradication: A Comparative Review of Laboratory and Preclinical Studies.

Authors:  Sophia Hawas; Anthony D Verderosa; Makrina Totsika
Journal:  Front Cell Infect Microbiol       Date:  2022-02-25       Impact factor: 5.293

7.  Bactericidal and anti-biofilm effects of uncharged and cationic ultrasound-responsive nitric oxide microbubbles on Pseudomonas aeruginosa biofilms.

Authors:  Gareth LuTheryn; Charlotte Hind; Christopher Campbell; Aaron Crowther; Qiang Wu; Sara B Keller; Peter Glynne-Jones; J Mark Sutton; Jeremy S Webb; Michael Gray; Sandra A Wilks; Eleanor Stride; Dario Carugo
Journal:  Front Cell Infect Microbiol       Date:  2022-08-04       Impact factor: 6.073

8.  Potential factors contributing to the poor antimicrobial efficacy of SAAP-148 in a rat wound infection model.

Authors:  Gabrielle S Dijksteel; Magda M W Ulrich; Marcel Vlig; Peter H Nibbering; Robert A Cordfunke; Jan W Drijfhout; Esther Middelkoop; Bouke K H L Boekema
Journal:  Ann Clin Microbiol Antimicrob       Date:  2019-12-03       Impact factor: 3.944

9.  Cell death and biomass reduction in biofilms of multidrug resistant extended spectrum β-lactamase-producing uropathogenic Escherichia coli isolates by 1,8-cineole.

Authors:  Nicolas M Vazquez; Florencia Mariani; Pablo S Torres; Silvia Moreno; Estela M Galván
Journal:  PLoS One       Date:  2020-11-05       Impact factor: 3.240

10.  A new BiofilmChip device for testing biofilm formation and antibiotic susceptibility.

Authors:  Núria Blanco-Cabra; Maria José López-Martínez; Betsy Verónica Arévalo-Jaimes; María Teresa Martin-Gómez; Josep Samitier; Eduard Torrents
Journal:  NPJ Biofilms Microbiomes       Date:  2021-08-03       Impact factor: 7.290

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.